XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income $ 419,486 $ 424,190
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 391,775 157,576
Amortization of deferred financing costs 7,739 5,470
Non-cash interest expense related to amortization of discount on Life Storage unsecured senior notes 21,558 0
Compensation expense related to share-based awards 6,192 12,439
Accrual of interest income added to principal of debt securities and notes receivable (16,100) (16,200)
Loss on real estate assets held for sale 54,659 0
Distributions from unconsolidated real estate ventures 14,540 7,594
Changes in operating assets and liabilities:    
Other assets (2,518) (28,129)
Accounts payable and accrued expenses 42,669 37,176
Other liabilities 70,800 29,411
Net cash provided by operating activities 1,010,800 629,527
Cash flows from investing activities:    
Acquisition of real estate assets and improvements (157,329) (127,416)
Development and redevelopment of real estate assets (69,384) (37,244)
Proceeds from sale of real estate assets and investments in real estate ventures 0 1,046
Investment in unconsolidated real estate entities (10,789) (171,126)
Return of investment in unconsolidated real estate ventures 4,200 0
Issuance and purchase of notes receivable (569,268) (124,103)
Principal payments received from notes receivable 47,455 46,466
Proceeds from sale of notes receivable 0 60,696
Purchase of equipment and fixtures (9,652) (5,905)
Net cash used in investing activities (764,767) (357,586)
Cash flows from financing activities:    
Proceeds from unsecured term loans and senior notes and revolving lines of credit 3,263,470 2,479,592
Principal payments on unsecured term loans and senior notes and revolving lines of credit (3,407,382) (3,246,378)
Proceeds from issuance of public bonds, net 600,000 950,000
Deferred financing costs (5,719) (28,151)
Proceeds from share issuances and redemption of stock options for cash, net 366 0
Redemption of Operating Partnership units for cash 0 (5,000)
Offering costs associated with shelf registration (494) 0
Dividends paid on common stock (687,636) (438,783)
Distributions to noncontrolling interests (32,177) (28,043)
Net cash used in financing activities (269,572) (316,763)
Net decrease in cash, cash equivalents, and restricted cash (23,539) (44,822)
Cash, cash equivalents, and restricted cash, beginning of the period 105,083 97,735
Cash, cash equivalents, and restricted cash, end of the period 81,544 52,913
Cash and cash equivalents 76,973 50,644
Restricted cash 4,571 2,269
Cash, cash equivalents, and restricted cash 81,544 52,913
Supplemental schedule of cash flow information    
Interest paid 230,242 150,459
Income taxes paid 22,034 11,831
Redemption of Operating Partnership units held by noncontrolling interests for common stock    
Noncontrolling interests in Operating Partnership 54,491 149,739
Common stock and paid-in capital (54,491) (44,739)
Noncontrolling interests in Operating Partnership Note Receivable Payoff 0 (100,000)
OP Unit Redemption - Cash Proceeds 0 (5,000)
Accrued Construction Costs And Capital Expenditures [Abstract]    
Acquisition of real estate assets 4,754 4,503
Accounts payable and accrued expenses $ (4,754) $ (4,503)